Minerva Neurosciences Announces Publication of Roluperidone Phase 3 Study Results in Schizophrenia Bulletin

News
1
5 Likes
2

Good news, hope it gets apprived by the FDA soon. We really need meds for negative and cognitive symptoms asap.

1 Like